In 2024, New Zealand leads in analgesic medicine use with 45.2 DDD per thousand persons per day, followed by Estonia at 42.8. Noteworthy increases in 2023 include Greece (23.27%) and Estonia (11.18%), while the Netherlands saw a significant decline of 10.94%. Luxembourg and Australia also observed a decrease, -2.89% and -2.06% respectively. Long-term, Germany, Belgium, and Slovenia have demonstrated steady increases, contrasting sharply with the declining trends in the Netherlands and Luxembourg. Overall, analgesic use varies significantly by region and economic status.
Future trends to monitor include the potential impact of emerging healthcare policies, increasing awareness campaigns on pain management, and technological advancements in pharmaceutical development. Additionally, observe potential shifts in consumer behavior regarding opioid alternatives and non-pharmacological pain relief methods.
Top countries in Analgesic Medicine Use by Country
| # | 10 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 New Zealand | 45.2 | 2023 | -4.03% | View data | |
| 2 | 2 Estonia | 42.8 | 2023 | +9.46% | +11.18% | View data |
| 3 | 3 Slovenia | 33.8 | 2023 | +3.36% | +4.75% | View data |
| 4 | 4 Germany | 33.6 | 2023 | +1.51% | +4.86% | View data |
| 5 | 5 Belgium | 33.3 | 2023 | +3.42% | +3.53% | View data |
| 6 | 6 Luxembourg | 28.5 | 2023 | +1.06% | -2.89% | View data |
| 7 | 7 Slovakia | 20.4 | 2023 | -0.49% | -0.29% | View data |
| 8 | 8 Costa Rica | 19.8 | 2023 | +13.14% | +2.15% | View data |
| 9 | 9 Australia | 15.5 | 2023 | 0% | -2.06% | View data |
| 10 | 10 South Korea | 12.6 | 2023 | 0% | +0.65% | View data |
